Fate Therapeutics, Inc. (FATE) Stock Price, Quote & News
https://stockanalysis.com/stocks/fate/
Web2 days ago · 6.61. -0.82 (-11.04%) At close: Mar 22, 2024, 4:00 PM. 6.82. +0.21 (3.18%) After-hours: Mar 22, 2024, 7:23 PM EDT. -11.04 ( 1D) About FATE. Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide.
DA: 62 PA: 7 MOZ Rank: 83